Furthermore, anti‐PD‐L1‐DOX‐R848‐MIP‐3α/TKNP‐treated mice showed increased intratumoral infiltration of CD4+ and CD8+ T cells and enhanced level of circulating and tumor‐infiltrated cytokines for better antitumor effect. The gene discussed is CD8A; the disease is neoplasm.